Molina, Jean-Michel

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial

Hermine, O., Mariette, X., Tharaux, P.-L., Resche-Rigon, M., Porcher, R., Ravaud, P., CORIMUNO-19 Collaborative Group, Bureau, S., Dougados, M., Tibi, A., et al. (2021) · JAMA Internal Medicine

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 734

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., et al. (2018) · JAMA

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 698

Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.

Molina, J.-M., Charreau, I., Chidiac, C., Pialoux, G., Cua, E., Delaugerre, C., Capitant, C., Rojas-Castro, D., Fonsart, J., Bercot, B., et al. (2018) · The Lancet Infectious Diseases

HIV/AIDS Research and InterventionsReproductive tract infections research

Cited by 449

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER) primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Mayer, K. H., Molina, J.-M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., DeJesus, E., Jessen, H., Grant, R. M., Ruane, P. J., et al. (2020) · The Lancet

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 428

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

Segal-Maurer, S., DeJesus, E., Stellbrink, H.-J., Castagna, A., Richmond, G. J., Sinclair, G. I., Siripassorn, K., Ruane, P. J., Berhe, M., Wang, H., et al. (2022) · New England Journal of Medicine

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 331

Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society-USA Panel

Gandhi, R. T., Landovitz, R. J., Sax, P. E., Smith, D. M., Springer, S. A., Günthard, H. F., Thompson, M. A., Bedimo, R. J., Benson, C. A., Buchbinder, S. P., et al. (2025) · JAMA

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 265

Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study

Lévy, Y., Sereti, I., Tambussi, G., Routy, J. P., Lelièvre, J. D., Delfraissy, J. F., Molina, J. M., Fischl, M., Goujard, C., Rodriguez, B., et al. (2012) · Clinical Infectious Diseases

HIV Research and TreatmentT-cell and B-cell Immunology

Cited by 240

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

Kozal, M., Aberg, J., Pialoux, G., Cahn, P., Thompson, M., Molina, J.-M., Grinsztejn, B., Diaz, R., Castagna, A., Kumar, P., et al. (2020) · New England Journal of Medicine

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 181

Disseminated Microsporidiosis Due To Septata intestinalis In Patients With AIDS: Clinical Features And Response To Albendazole Therapy

Molina, J.-M., Oksenhendler, E., Beauvais, B., Sarfati, C., Jaccard, A., Derouin, F., & Modai, J. (1995) · Journal of Infectious Diseases

Parasitic Infections and DiagnosticsViral gastroenteritis research and epidemiology

Cited by 138

Intestinal Microsporidiosis in Human Immunodeficiency Virus-Infected Patients with Chronic Unexplained Diarrhea: Prevalence and Clinical and Biologic Features

Molina, J.-M., Sarfati, C., Beauvais, B., Lemann, M., Lesourd, A., Ferchal, F., Casin, I., Lagrange, P., Modigliani, R., Derouin, F., et al. (1993) · Journal of Infectious Diseases

Parasitic Infections and DiagnosticsViral gastroenteritis research and epidemiology

Cited by 132

Herpes Simplex Virus Type 2 as a Cause of Severe Meningitis in Immunocompromised Adults

Mommeja-Marin, H., Lafaurie, M., Scieux, C., Galicier, L., Oksenhendler, E., & Molina, J.-M. (2003) · Clinical Infectious Diseases

Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus research

Cited by 76

Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection

Molina, J.-M., Goguel, J., Sarfati, C., Michiels, J.-F., Desportes-Livage, I., Balkan, S., Chastang, C., Cotte, L., Maslo, C., Struxiano, A., et al. (2000) · AIDS

Parasitic Infections and DiagnosticsViral gastroenteritis research and epidemiology

Cited by 71

Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial

Ogbuagu, O., Molina, J.-M., Chetchotisakd, P., Ramgopal, M. N., Sanchez, W., Brunetta, J., Castelli, F., Crofoot, G. E., Hung, C.-C., Ronot-Bregigeon, S., et al. (2025) · Clinical Infectious Diseases

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 44

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial

Morales-Ramirez, J., Bogner, J. R., Molina, J.-M., Lombaard, J., Dicker, I. B., Stock, D. A., DeGrosky, M., Gartland, M., Pene Dumitrescu, T., Min, S., et al. (2018) · PLOS ONE

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 44

Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis.

Gras, J., Mahjoub, N., Charreau, I., Cotte, L., Tremblay, C., Chas, J., Raffi, F., Cua, E., Guillon, B., Guigue, N., et al. (2020) · AIDS

Hepatitis C virus researchHIV, Drug Use, Sexual Risk

Cited by 28

Genetically intact but functionally impaired HIV-1 env glycoproteins in the T-cell reservoir

de Verneuil, A., Migraine, J., Mammano, F., Molina, J.-M., Gallien, S., Mouquet, H., Hance, A. J., Clavel, F., & Dutrieux, J. (2018) · Journal of Virology

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 10

Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial

Moyle, G., Assoumou, L., de Castro, N., Post, F. A., Curran, A., Rusconi, S., De Wit, S., Stephan, C., Raffi, F., Johnson, M., et al. (2024) · The Lancet HIV

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 6

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers

Hage-Sleiman, M., Tremeaux, P., Fillion, M., Boufassa, F., Melard, A., Gardiennet, E., Mariaggi, A.-A., Plantier, J.-C., Rouzioux, C., Lambotte, O., et al. (2020) · Clinical Infectious Diseases

HIV Research and TreatmentHIV/AIDS Research and Interventions

Cited by 2